Neurotransmission in human brains measured by 3D-PET
通过 3D-PET 测量人脑的神经传递
基本信息
- 批准号:08044235
- 负责人:
- 金额:$ 8.38万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for international Scientific Research
- 财政年份:1996
- 资助国家:日本
- 起止时间:1996 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Positron emission tomography (PET) is a unique method to examine brain chemistry non-invasively in humans.Using PET techniques, specific neurochemical systems, such as dopaminergic and histaminergic neuronal systems, was measured in the living human brain. For HA receptors, specific radiotracers for selective labeling of H3 receptors was newly synthesized. We also developed several new methods of imaging in the human brain using 3-demensional PET system. Our developed PET methods for human neuropharmacology are as follows : Non-invasive measurement of receptor binding parameters ; cerebral activation study with H_2^<15>O and 3D-PET ; "C-ligand activation study to measute neurotransmitter release. In this project, we were mainly focus on the PET studies of histaminergic neuron system in the human brain.Antihistamines are the efficacious drugs to be used for the symptomatic relief of allergic diseases. The safety issue of antihistamines is of central importance because of their widesprea … More d use in current medical practice. PET was used to better understand the pharmacological effects of antihistamines on the central nervous system. The H1 receptor occupancy was examined in young male volunteers with [^<11>C]-doxepin (a potent H1 antagonist) after the oral or intravenous administration of antihistamines. In other studies, the cognitive performance was also measured tachistoscopically before and after taking antihistamines. The H1 receptor occupancy in the human frontal cortex caused by antihistamines is significantly correlated with the reported values of incidence of sleepiness in clinical trials, and the occupancy is well proportional to the impaired cognitive performance. To understand the brain mechanism of antihistamine-induced "sleepiness and impaired cognition", the regional cerebral blood flow (rCBF) during the task was measured using 3D-PET and H_2^<15>O before and after administration of d-chlorpheniramine. After its administration, the rCBF was significantly decreased on the bilateral middle temporal gyrus, midbrain and anterior cingulate. These findings suggest that H1 receptor blockade would be affected on the activity of the attention and cognitive system in the brain. Less
正电子发射断层扫描(PET)是一种独特的非侵入性脑化学检查方法,使用PET技术,可以测量活体人脑中特定的神经化学系统,如多巴胺能和组胺能神经系统。对于HA受体,新合成了用于选择性标记H3受体的特异性放射性示踪剂。我们还开发了几种新的方法成像在人脑中使用三维PET系统。我们开发的用于人类神经药理学的PET方法如下:受体结合参数的无创测量; H_2^ O和3D-PET脑激活研究<15>; C-配体激活研究以测量神经递质释放。本课题主要研究人脑组胺能神经元系统的PET显像。抗组胺药是治疗过敏性疾病的有效药物。抗组胺药的安全性问题是至关重要的,因为它们具有预防作用。 ...更多信息 D在当前的医疗实践中使用。PET用于更好地了解抗组胺药对中枢神经系统的药理作用。年轻男性志愿者<11>口服或静脉注射抗组胺药后,用[^ C]-多塞平(一种有效的H1拮抗剂)检查H1受体结合率。在其他研究中,认知表现也在服用抗组胺药前后进行了速示检查。由抗组胺药引起的人类额叶皮层中的H1受体占用与临床试验中报告的嗜睡发生率值显著相关,并且占用与受损的认知表现成正比。为了解抗组胺药引起“嗜睡和认知障碍”的脑机制,应用3D-PET和H_2^ O测定了d-氯苯那敏(d-chlorpheniramine,d-氯苯那敏)治疗前后大鼠作业过程中局部脑血流量(rCBF)<15>的变化。给药后,双侧颞中回、中脑和扣带回前部的rCBF显著降低。这些发现表明,H1受体阻断剂会影响大脑中注意和认知系统的活动。少
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Yanai,et al: "Behavioral characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H.receptors" Neuroscience. 87. 479-487 (1998)
K.Yanai 等人:“缺乏组胺 H. 受体的小鼠的行为特征和脑单胺及其代谢物的量”神经科学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N.Sakai,et al.: "Depletion of brain histamine induced by α-fluoromethyl histidive enhances radial maze permormance in rats with modulation" Life Sci. 62. 989-994 (1998)
N.Sakai 等人:“α-氟甲基组胺诱导的脑组胺消耗通过调节增强大鼠的径向迷宫表现”Life Sci. 62. 989-994 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
谷内一彦、樋口真人、伊藤正敏、渡邉建彦: "PETによる脳機能測定、インビボレセプターマッピング" ブレインサイエンス. 7巻. 155-164 (1996)
Kazuhiko Taniuchi、Masato Higuchi、Masatoshi Ito、Takehiko Watanabe:“通过 PET 进行脑功能测量,体内受体图谱”《脑科学》第 7 卷。155-164 (1996)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N.Sakai, et al: "Depletion oh brain histamine induced by α-fluoromethylhistidie enhances radial maze performance in rats with modulation of brai" Life Sci. 62. 989-994 (1998)
N.Sakai 等人:“α-氟甲基组胺诱导的脑组胺消耗增强了大鼠的放射状迷宫表现”Life Sci. 62. 989-994 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T.Nakamura, Y.Hayashi, H.Watabe, M.Matsumoto, T.Horikawa, T.Fujiwara, M.Itoh and K.Yanai: "Estimation of organ cumulated activities and absorbed doses on intakes of several ^<11>C labeled radiopharmaceuticals from external measurement with thermoluminesce
T.Nakamura、Y.Hayashi、H.Watabe、M.Matsumoto、T.Horikawa、T.Fujiwara、M.Itoh 和 K.Yanai:“估计摄入几个 ^<11>C 的器官累积活动和吸收剂量
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YANAI Kazuhiko其他文献
YANAI Kazuhiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YANAI Kazuhiko', 18)}}的其他基金
Molecular mechanism of brain histamine clearance
脑组胺清除的分子机制
- 批准号:
26670117 - 财政年份:2014
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Integrated research of histamine system from molecular to wholeanimals and humans using leading-edge technologies
利用尖端技术对组胺系统从分子到整个动物和人类进行综合研究
- 批准号:
21390171 - 财政年份:2009
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Neuropharmacology on histamine system : From basic to clinical investigation on unsolved issues
组胺系统的分子神经药理学:从基础到临床研究未解决的问题
- 批准号:
19390061 - 财政年份:2007
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study of the histamine neuron system : Its correlation to newly-discovered hypothalamic peptides.
组胺神经元系统的研究:其与新发现的下丘脑肽的相关性。
- 批准号:
14370027 - 财政年份:2002
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The new perspectives of knockout mice and positron emission temography in the development and evaluation of drugs
基因敲除小鼠和正电子发射成像在药物开发和评价中的新视角
- 批准号:
12557007 - 财政年份:2000
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The development for novel positron-labeled radiopharmaceuticals and their application to measurement of the cerebral functions
新型正电子标记放射性药物的研制及其在脑功能测量中的应用
- 批准号:
11694234 - 财政年份:1999
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Application of positron-labeled radiopharmaceuticals and 3-D PET to Neuroscience
正电子标记放射性药物和 3-D PET 在神经科学中的应用
- 批准号:
07558107 - 财政年份:1995
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Imaging of neurotransmission in humnan brains : Normal and abnormal aging.
人脑神经传递成像:正常和异常衰老。
- 批准号:
06833002 - 财政年份:1994
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
深度学习驱动的PET/CT虚拟成像动态评估弥漫大B细胞淋巴瘤疗效的研究
- 批准号:JCZRLH202500761
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
靶向衰老标志物uPAR的PET分子影像技术构建及其可视化实验研究
- 批准号:MS25H180033
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
长轴PET/CT扫描下的质子治疗后人体内核素活化特征与组织剂量预测的研究
- 批准号:JCZRLH202500531
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
靶向mRNA-LNP体内原位编程FAP-CAR-M细胞治疗肝纤维化的PET显像示踪及疗效监测
- 批准号:JCZRYB202500706
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
突聋伴耳鸣相关皮层重组:18F-SynVesT-1/PET 显像研究
- 批准号:2025JJ80691
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于双时间相18F-FDG PET/CT显像多参数对胆管上皮癌亚型治疗决策的影响与分子靶点的相关性研究
- 批准号:2025JJ80709
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Trop-2特异性免疫PET探针精准诊疗非小细胞肺癌的实验研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
熔盐电解法制备原子级分散催化剂及其电催化PET废塑料制备高附加值化学品研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相转移催化强化疏水性传质协同碳酸二甲酯定向转化乙二醇解聚PET机制
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于PET/MR生境成像与单细胞—空间转录组学探讨胶质母细胞瘤恶性细胞状态可塑性的驱动机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Fully Bayesian 3D PET-MR Neuroimaging Reconstruction
完全贝叶斯 3D PET-MR 神经影像重建
- 批准号:
2886403 - 财政年份:2023
- 资助金额:
$ 8.38万 - 项目类别:
Studentship
basis of PET performance tests, PET quantification value calobration on 3D-PET among facility
PET性能测试的基础,设备间3D-PET的PET定量值校准
- 批准号:
23591790 - 财政年份:2011
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
3D PET Reconstruction Using Generalized Natural Pixels
使用广义自然像素进行 3D PET 重建
- 批准号:
7660259 - 财政年份:2009
- 资助金额:
$ 8.38万 - 项目类别:
Fundamental experiments for a quantitative myocardial blood flow measurement in 3D-PET
3D-PET 定量心肌血流测量的基础实验
- 批准号:
21791237 - 财政年份:2009
- 资助金额:
$ 8.38万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
3D PET Reconstruction Using Generalized Natural Pixels
使用广义自然像素进行 3D PET 重建
- 批准号:
7753195 - 财政年份:2009
- 资助金额:
$ 8.38万 - 项目类别:
Strategies for Clinical Oncology Imaging with 3D PET
3D PET 临床肿瘤成像策略
- 批准号:
6730034 - 财政年份:1997
- 资助金额:
$ 8.38万 - 项目类别:
STRATEGIES FOR CLINICAL ONCOLOGY IMAGING WITH 3D PET
3D PET 临床肿瘤成像策略
- 批准号:
2012127 - 财政年份:1997
- 资助金额:
$ 8.38万 - 项目类别:
STRATEGIES FOR CLINICAL ONCOLOGY IMAGING WITH 3D PET
3D PET 临床肿瘤成像策略
- 批准号:
2895929 - 财政年份:1997
- 资助金额:
$ 8.38万 - 项目类别:
STRATEGIES FOR CLINICAL ONCOLOGY IMAGING WITH 3D PET
3D PET 临床肿瘤成像策略
- 批准号:
6173153 - 财政年份:1997
- 资助金额:
$ 8.38万 - 项目类别:
Strategies for Clinical Oncology Imaging with 3D PET
3D PET 临床肿瘤成像策略
- 批准号:
7060858 - 财政年份:1997
- 资助金额:
$ 8.38万 - 项目类别:














{{item.name}}会员




